LPAR3 and cancer: This crosstalk between RTK and GPCR signalling systems regulates several cellular processes; the dysfunctional signal integration between the two receptors may sometimes result in a variety of disease states, such as cardiovascular and renal disorders, obesity, metabolic syndrome, type diabetes mellitus, cancer, etc. The understanding of GPCR activation is fundamental for targeted cancer therapy.